Redox Disruption Induced by Saquayamycin B1 Promotes Cytotoxicity in Resistant Melanoma Cells

Geovana Guedes Silvestre1, Thalisson Amorim de Souza1, Alan Ferreira Alves1

  • 1Postgraduate Program of Bioactives Natural and Synthetics Products, PgPNSB, Federal University of Paraíba, João Pessoa, Brazil.

Chemmedchem
|May 22, 2026
PubMed

Insights

Saquayamycin B1, an angucycline, shows potent antimelanoma activity by disrupting cellular redox balance. This compound effectively targets key redox regulators, offering a promising avenue for treating chemoresistant melanoma.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Melanoma is an aggressive skin cancer with limited treatment success due to rapid progression and chemoresistance.
  • Targeting redox pathways presents a potential strategy to overcome therapeutic limitations in melanoma.

Purpose of the Study:

  • To investigate the antimelanoma activity of Saquayamycin B1 (SQ-B1), an angucycline.
  • To elucidate the mechanism of SQ-B1's action, focusing on its impact on cellular redox balance.

Main Methods:

  • Purification of SQ-B1 from Streptomyces sp. I072 via M9 fermentation and chromatography.
  • Structure elucidation using 1D/2D NMR and mass spectrometry.
  • Cytotoxicity assays (MTT) on human melanoma cell lines (SK-MEL-5, -113, -117, -134).
  • Assessment of reactive oxygen species (ROS) and glutathione levels.
  • Molecular docking and dynamics simulations to identify target proteins.

Main Results:

  • SQ-B1 exhibited significant cytotoxicity against melanoma cells with IC50 values ranging from 0.99 to 5.01 μM.
  • N-acetylcysteine (NAC) pretreatment rescued cell viability, confirming a ROS-dependent mechanism.
  • SQ-B1 treatment decreased the GSH/GSSG ratio and increased superoxide (O2•−) and nitric oxide (NO•) levels, indicating oxidative stress.
  • Molecular docking predicted strong binding of SQ-B1 to glutathione transferase (GSTP1-1) and glutathione reductase (GSR).
  • Molecular dynamics confirmed stable interactions between SQ-B1 and GSR.

Conclusions:

  • SQ-B1 induces melanoma cell cytotoxicity by disrupting the cellular redox balance.
  • The compound effectively targets key redox-regulating enzymes like GSR.
  • SQ-B1 demonstrates potential as a novel redox-modulating therapeutic agent for chemoresistant melanoma.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...